About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Ohio | 521 Studies

Clinical Trials Prostate CancerOhio

Prostate Cancer Clinical Trials in Ohio

Find 521 clinical trials for prostate cancer near Ohio. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 401-420 of 521 trials

Active not recruitingA Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate CancerThe purpose of this study is to determine the recommended Phase 2 dose(s) (RP2D\[s\]) of JNJ-69086420 in Part 1 (Dose Escalation), to determine safety and preliminary signs of…NCT04644770·Phoenix, Arizona and 10 others TerminatedAn Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate CancerThis Phase 2 Open-label Study examines the efficacy, safety, tolerability, and pharmacokinetics (PK) of tomivosertib (eFT508) in Patients with advanced CRPC.NCT03690141·New Haven, Connecticut and 9 others CompletedVinflunine in Hormone Refractory Prostate Cancer (HRPC)Currently, there are no established 2nd-line or salvage chemotherapy regimens for patients with HRPC, many of whom retain an excellent performance status.NCT00545766·Fort Myers, Florida and 11 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedPositive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate CancerThe primary purpose of this research is to describe patient characteristics predictive of an imaging study positive for distant metastases in patients with castration-resistant…NCT01981109·Anchorage, Alaska and 57 others

CompletedA Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate CancerThe purpose of this study is to determine whether PROSTVAC alone or in combination with GM-CSF is effective in prolonging overall survival in men with few or no symptoms from…NCT01322490·Anchorage, Alaska and 219 others

CompletedSpaceOAR System Pivotal StudyEvaluate the safety of the SpaceOAR System when the hydrogel is injected between the rectum and prostate in men undergoing radiation therapy (IG-IMRT)NCT01538628·Phoenix, Arizona and 19 others

CompletedBicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate CancerThis randomized phase II trial is studying bicalutamide, goserelin, or leuprolide acetate to see how well they work when given with or without cixutumumab in treating patients…NCT01120236·Fairbanks, Alaska and 169 others

CompletedNAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer PatientsAfrican-Americans have disparately limited access to optimal cancer care.NCT05978232·Cleveland, Ohio

CompletedPhase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate CancerThe VIABLE study sought to confirm the hypothesis that the combination of docetaxel with DCVAC/PCa followed by a maintenance therapy with DCVAC/PCa would improve overall survival…NCT02111577·Mobile, Alabama and 176 others

RecruitingTesting the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine CellsThis phase II trial studies how well lutetium Lu 177 dotatate works in treating patients with prostate cancer with neuroendocrine differentiation that has spread to other places…NCT05691465·Duarte, California and 12 others

CompletedS0000 Selenium and Vitamin E in Preventing Prostate CancerRATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer.NCT00006392·Chicago, Illinois and 12 others

WithdrawnStudy of NUV-422 in Combination With Enzalutamide in Patients With mCRPCNUV-422-04 is an open-label Phase 1b/2 dose escalation and expansion study designed to evaluate the safety and efficacy of NUV-422 in combination with enzalutamide.NCT05191017·Canton, Ohio and 2 others

CompletedA Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate CancerThe purpose of this study is to evaluate the efficacy of TAK 385 for achieving and maintaining testosterone suppression (\<50 ng/dL).NCT02083185·Birmingham, Alabama and 22 others

CompletedObservational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate CancerObservational study in the routine clinical practice setting to evaluate the short and long term safety profile of Radium-223 in metastatic castration resistant prostate cancer…NCT02141438·Anchorage, Alaska and 67 others

CompletedR115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005848·Cleveland, Ohio and 1 other

RecruitingA Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)Himalayas-1 is a randomized, open-label, global, multicenter phase 3 study evaluating whether the combination of rinzimetostat with darolutamide is more effective compared to…NCT07723248·Jeffersonville, Indiana and 6 others

CompletedGM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate CancerRATIONALE: Biological therapies, such as GM-CSF, may stimulate the immune system in different ways and stop tumor cells from growing.NCT00400517·Cleveland, Ohio

RecruitingStudy of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)This is a phase 3, randomized, open-label study of opevesostat compared to alternative abiraterone acetate or enzalutamide in participants with metastatic castration-resistant…NCT06136624·Orange, California and 287 others

CompletedA Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate CancerThe primary purpose of this study is to determine the safest dose of ZD4054 (Zibotentan)in men with prostate cancerNCT00055471·Cleveland, Ohio and 1 other

CompletedRadiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells and shrink tumors. Androgens can cause the growth of prostate cancer cells.NCT00936390·Birmingham, Alabama and 517 others

PreviousPage 21 of 27Next

Other Conditions in Ohio

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma